Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS, Industry To Debate “Practical” Trials On July 20 Audio Conference

Executive Summary

The benefits and pitfalls of "practical clinical trials" for drugs and devices will be debated during a July 20 Drug & Device Dialogue 1audio conference

You may also be interested in...

Pfizer, Novartis Learning The VALUE Of Comparative Research

A Novartis-sponsored study comparing Diovan to Pfizer's Norvasc highlights the risk firms take in conducting comparative research

FDA Mission Should Not Include Rx Cost-Effectiveness, Rep. Allen Says

FDA is not the appropriate agency to oversee comparative research involving drugs and devices, Rep. Tom Allen (D-Maine) says

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts